Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Statera Biopharma, Inc. See All Filings	D	2022-11-04 18:59:09 UTC
Amount To Be Raised $764,500 Associated Brokers / Dealers N/A CIK Number 0001318641 Filed Document 0001437749-22-026086 Exclusions or Exemptions 506b Accepted Date 2022-11-04 18:59:09 UTC Type of Offering D Industry Biotechnology Principal Place of Business COLORADO Revenue or Assets $$1,000,001 - $5,000,000 Type of Security Equity
CLEVELAND BIOLABS INC See All Filings	D	2020-06-04 17:15:14 UTC
Amount To Be Raised $1,588,262 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001318641 Filed Document 0001437749-20-012488 Exclusions or Exemptions 506b Accepted Date 2020-06-04 17:15:14 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
CLEVELAND BIOLABS INC See All Filings	D	2015-12-23 00:00:00 UTC
Amount To Be Raised $1,140,157 Associated Brokers / Dealers N/A CIK Number 0001318641 Filed Document 0001015325-15-000033 Exclusions or Exemptions 506b Accepted Date 2015-12-23 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
CLEVELAND BIOLABS INC See All Filings	D	2015-07-16 00:00:00 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers Ladenburg & Thalmann & Co., Inc. CIK Number 0001318641 Filed Document 0001318641-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-07-16 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
CLEVELAND BIOLABS INC See All Filings	D	2014-07-02 00:00:00 UTC
Amount To Be Raised $3,500,000 Associated Brokers / Dealers H.C.WAINWRIGHT & CO., LLC CIK Number 0001318641 Filed Document 0001318641-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-07-02 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity